Pfizer Agrees to Settle 10,000 Zantac Lawsuits Over Alleged Cancer Risks, Bloomberg Reports
-- Pfizer has agreed to settle over 10,000 cases against its heartburn drug Zantac for allegedly hiding cancer-associated risks, Bloomberg reports, citing people familiar with the deal.
-- The agreements cover cases in state courts across the U.S., but don't completely resolve the company's exposure to Zantac claims, Bloomberg reports.
-- "Pfizer has explored and will continue to explore opportunistic settlements of certain cases if appropriate, and has settled certain cases," Pfizer said in a statement, according to Bloomberg. "The company has not sold a Zantac product in more than 15 years and did so only for a limited period of time."
-- Zantac has been owned by different drugmakers in its more than 30-year run as one of the most popular antacids in the U.S., Bloomberg reports.
Full article at https://www.bloomberg.com/news/articles/2024-05-08/pfizer-agrees-to-settle-more-than-10-000-zantac-cancer-lawsuits
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
May 08, 2024 13:47 ET (17:47 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: Tech Stocks Lead Ahead of Nvidia Earnings
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing